1200.131.08153 Boehringer Ingelheim Investigational Site

Chiba, Kashiwa

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Neoplasms

Studies at this site

• LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy — Stopped early